BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31913156)

  • 21. Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.
    Suster DI; Gross JM; Fayad L; Wenokor C; Goldsmith JD; Ward A; Early C; Lazano-Calderon S; Klein MJ
    Skeletal Radiol; 2024 Feb; 53(2):387-393. PubMed ID: 37524934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
    Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
    Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic Sclerosing Epithelioid Fibrosarcoma in Bone Marrow.
    Asakra R; Zaidi S; Thway K
    Int J Surg Pathol; 2017 Dec; 25(8):702-704. PubMed ID: 28697683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
    Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
    Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
    Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
    Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.
    Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK
    Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
    Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
    Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
    J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma.
    Wang WL; Evans HL; Meis JM; Liegl-Atzwanger B; Bovee JV; Goldblum JR; Billings SD; Rubin BP; López-Terrada D; Lazar AJ
    Mod Pathol; 2012 Jun; 25(6):846-53. PubMed ID: 22388756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
    Blay JY; Tlemsani C; Toulmonde M; Italiano A; Rios M; Bompas E; Valentin T; Duffaud F; Le Nail LR; Watson S; Firmin N; Dubray-Longeras P; Ropars M; Perrin C; Hervieu A; Lebbe C; Saada-Bouzid E; Soibinet P; Fiorenza F; Bertucci F; Boudou P; Vaz G; Bonvalot S; Honoré C; Marec-Berard P; Minard V; Cleirec M; Biau D; Meeus P; Babinet A; Dumaine V; Carriere S; Fau M; Decanter G; Gouin F; Ngo C; Le Loarer F; Karanian M; Meurgey A; Dufresne A; Brahmi M; Chemin-Airiau C; Ducimetiere F; Penel N; Le Cesne A;
    Eur J Cancer; 2024 Jan; 196():113454. PubMed ID: 38008029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerosing Epithelioid Fibrosarcoma of the Liver in a Pediatric Patient.
    Armstrong A; Boulos F; Kulkarni S; Stoll J; Doyle MBM; Khan A; He M
    Pediatr Dev Pathol; 2023; 26(2):153-160. PubMed ID: 36748108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location.
    Ohlmann CH; Brecht IB; Junker K; van der Zee JA; Nistor A; Bohle RM; Stöckle M; Metzler M; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):221-5. PubMed ID: 25990776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion.
    Argani P; Lewin JR; Edmonds P; Netto GJ; Prieto-Granada C; Zhang L; Jungbluth AA; Antonescu CR
    Am J Surg Pathol; 2015 Mar; 39(3):365-73. PubMed ID: 25353281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics.
    Cloutier JM; Moreland A; Wang L; Kunder CA; Allard G; Wang A; Krings G; Charville GW; Bean GR
    Hum Pathol; 2023 Sep; 139():17-26. PubMed ID: 37392946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerosing Epithelioid Fibrosarcoma of the Kidney: First Reported Case in a Young Child.
    Kurtz JL; Tan SY; Hazard FK
    Pediatr Dev Pathol; 2021; 24(2):148-153. PubMed ID: 33470922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A hybrid lesion: Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF)].
    Kesrouani C; Zemoura L; Trassard M; Laé M
    Ann Pathol; 2016 Oct; 36(5):351-354. PubMed ID: 27641819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
    Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
    Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
    Zhang L; Luo L; Liu C; Li Z
    Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.
    Folk GS; Williams SB; Foss RB; Fanburg-Smith JC
    Head Neck Pathol; 2007 Sep; 1(1):13-20. PubMed ID: 20614275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.